Glyset and Levaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 6 people who take Glyset and Levaquin. Common interactions include electrocardiogram qt prolonged among females, and electrocardiogram qt prolonged among males.

The phase IV clinical study analyzes what interactions people who take Glyset and Levaquin have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

6 people who take Glyset and Levaquin together, and have interactions are studied.

What is Glyset?

Glyset has active ingredients of miglitol. Currently, eHealthMe is studying from 355 Glyset users.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is used in sinusitis. Currently, eHealthMe is studying from 56,103 Levaquin users.

Number of Glyset and Levaquin reports submitted per year:

Common Glyset and Levaquin drug interactions by gender *:

female:

Electrocardiogram qt prolonged

male:

Electrocardiogram qt prolonged
Abdominal discomfort
Asthenia
Atelectasis
Azotaemia
Balance disorder
Cardiac failure congestive
Cardiac murmur
Cardiovascular disorder
Cardiovascular insufficiency

Common Glyset and Levaquin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Abdominal discomfort
Abscess
Atelectasis
Azotaemia
Balance disorder
Cardiac failure congestive
Cardiac murmur
Cardiovascular disorder
Cardiovascular insufficiency
Cellulitis

* Approximation only. Some reports may have incomplete information.

Do you take Glyset and Levaquin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .

Related studies

Drug side effects by duration, gender and age:

Glyset side effects (355 reports)
Levaquin side effects (56,103 reports)

Browse interactions between Glyset and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levaquin drug interactions:

Levaquin and Prednisone: 6,978 reports
Levaquin and Aspirin: 5,318 reports
Levaquin and Protonix: 4,162 reports
Levaquin and Nexium: 4,001 reports
Levaquin and Lasix: 3,780 reports
Levaquin and Prilosec: 3,624 reports
Levaquin and Lisinopril: 3,504 reports
Levaquin and Tylenol: 3,276 reports
Levaquin and Albuterol: 3,262 reports
Levaquin and Cipro: 3,058 reports

Browse interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on miglitol and levofloxacin (the active ingredients of Glyset and Levaquin, respectively), and Glyset and Levaquin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Glyset and Levaquin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Robitussin and Piperacillin drug interaction - 3 seconds ago
Mirapex and Topamax drug interaction - 6 seconds ago
Ramipril and Hypothyroidism - 16 seconds ago
Clorazepate Dipotassium and Prevacid drug interaction - 21 seconds ago
Sevoflurane and Oropharyngeal Discomfort - 21 seconds ago
Femring and Headache - 30 seconds ago
Lariam and High Blood Pressure - a minute ago
Sandostatin and Estrogel drug interaction - a minute ago
Spironolactone and Urinary Tract Infection Bacterial - a minute ago
Halflytely and Sucralfate drug interaction - a minute ago